Company Profile
NeuroOne Medical Technologies Stock Price, News & Catalysts
- Ticker:
- NMTC
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.13 USD (+1.35%)
Close
Last updated: October 6, 2026
30.7M USD
Market cap
Why the stock is moving
The latest company update was “NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order”. NMTC changed 0.45% and closed at $1.11 on Oct 5, 2026, indicating a relatively limited closing-price reaction to this company update.
Company overview
Neurotechnology Medical Device Company
NeuroOne Medical Technologies develops minimally invasive devices for recording, monitoring, stimulating, and ablating nervous-system tissue. Its products are designed for neurosurgery, epilepsy care, and other neurological procedures.
Evo Electrode Portfolio
The Evo cortical and stereoelectroencephalography electrodes record electrical activity from the brain and can support stimulation. Thin-film construction is intended to improve conformability and reduce device bulk during diagnostic monitoring.
OneRF Ablation System
OneRF uses radiofrequency energy through implanted electrodes to ablate targeted brain tissue. The system is designed to let clinicians diagnose and treat selected neurological conditions using the same access pathway.
Trigeminal Neuralgia Application
NeuroOne has developed a OneRF system for procedures involving the trigeminal nerve. This expands the platform beyond epilepsy and brain-tumor workflows into treatment of severe facial pain.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of NeuroOne Medical Technologies (NMTC)?
NeuroOne Medical Technologies (NMTC) most recently closed at 1.13 USD, a +1.35% move versus the previous session.
What is the market cap of NeuroOne Medical Technologies (NMTC)?
NeuroOne Medical Technologies currently has a market capitalization of 30.7M USD on BioPharmSignal.
What does NeuroOne Medical Technologies do?
Neurotechnology Medical Device Company NeuroOne Medical Technologies develops minimally invasive devices for recording, monitoring, stimulating, and ablating nervous-system tissue. Its products are designed for neurosurgery, epilepsy care, and other neurological procedures. Evo Electrode Portfolio The Evo cortical and stereoelectroencephalography electrodes...
On which exchange is NMTC stock listed?
NeuroOne Medical Technologies (NMTC) is associated with NASDAQ, United States, Biopharma.
What is Neurotechnology?
Neurotechnology Medical Device Company NeuroOne Medical Technologies develops minimally invasive devices for recording, monitoring, stimulating, and ablating nervous-system tissue.
Which conditions is NeuroOne Medical Technologies targeting with Neurotechnology?
Neurotechnology Medical Device Company NeuroOne Medical Technologies develops minimally invasive devices for recording, monitoring, stimulating, and ablating nervous-system tissue. Its products are designed for neurosurgery, epilepsy care, and other neurological procedures. Evo Electrode Portfolio The Evo cortical and stereoelectroencephalography electrodes...
What is Medical?
Neurotechnology Medical Device Company NeuroOne Medical Technologies develops minimally invasive devices for recording, monitoring, stimulating, and ablating nervous-system tissue.
What is Device?
Neurotechnology Medical Device Company NeuroOne Medical Technologies develops minimally invasive devices for recording, monitoring, stimulating, and ablating nervous-system tissue.